{
    "clinical_study": {
        "@rank": "18347", 
        "arm_group": {
            "arm_group_label": "Saline injection with ID adapters", 
            "arm_group_type": "Experimental", 
            "description": "Each participant will receive six injections of 0.1 ml of sterile saline solution into the skin:\nUpper deltoid with the side-load ID adapter\nUpper deltoid with the AD ID adapter\nSuprascapular (behind the shoulder) with the side-load ID adapter\nSuprascapular with the AD ID adapter\nForearm with the side-load ID adapter\nForearm with the AD ID adapter"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery\n      devices can safely and precisely inject liquid into the intradermal layer of the skin in\n      three different injection locations"
        }, 
        "brief_title": "Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Injections, Intradermal", 
        "detailed_description": {
            "textblock": "This study is a preliminary device safety and performance evaluation in healthy adult\n      volunteers (ages 18-55 years).\n\n      Each participant will receive six injections of 0.1 ml of sterile saline solution into the\n      skin:\n\n        -  Upper deltoid with the side-load ID adapter\n\n        -  Upper deltoid with the autodisable (AD) ID adapter\n\n        -  Suprascapular (behind the shoulder) with the side-load ID adapter\n\n        -  Suprascapular with the AD ID adapter\n\n        -  Forearm with the side-load ID adapter\n\n        -  Forearm with the AD ID adapter\n\n      Intradermal administration of each injection will be assessed:\n\n        -  The liquid remaining on the surface of the skin will be blotted with absorbent paper\n           and the amount of liquid present will be recorded.\n\n        -  The formation of an intradermal wheal will be observed, and the diameter of the wheal\n           measured using a ruler or similar measurement tool.\n\n        -  A photo of the injection site will be taken.\n\n      Injections will be assessed for safety by observation of injection sites for any local\n      adverse events."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female and male participants ages 18 to 55 years.\n\n          -  Healthy enough to participate in the clinical trial per site investigator assessment.\n\n          -  Healthy skin on the upper deltoid, suprascapular, and forearm regions (both sides of\n             the body).\n\n          -  Able to provide signed informed consent and understand study procedures per ICH/GCP\n             guidelines.\n\n          -  Literate in English.\n\n          -  Available by telephone 48 hours after the study visit.\n\n        Exclusion Criteria:\n\n        - Skin abnormalities on upper deltoid, suprascapular, and forearm regions of either side\n        of the body (scars, rash, infection), tattoo at the injection site, or other skin\n        conditions that would interfere with the ability to visualize an intradermal injection in\n        the opinion of the investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943110", 
            "org_study_id": "HS 720"
        }, 
        "intervention": [
            {
                "arm_group_label": "Saline injection with ID adapters", 
                "description": "Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin. Contains an autodisable feature to prevent reuse.", 
                "intervention_name": "ID adapter (autodisable)", 
                "intervention_type": "Device", 
                "other_name": [
                    "Autodisable intradermal adapter", 
                    "AD ID adapter"
                ]
            }, 
            {
                "arm_group_label": "Saline injection with ID adapters", 
                "description": "Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin.", 
                "intervention_name": "ID adapter (side load)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Intradermal injections", 
            "Vaccine delivery devices"
        ], 
        "lastchanged_date": "September 11, 2013", 
        "link": {
            "url": "http://www.path.org/our-work/vaccine-delivery.php"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Renton", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98057"
                }, 
                "name": "Rainier Clinical Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Clinical Trial to Evaluate the Performance and Safety of Two Intradermal Delivery Devices.", 
        "overall_official": {
            "affiliation": "Rainier Clinical Research Center", 
            "last_name": "Leslie Klaff, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The proportion of saline injections resulting in delivery to the intradermal layer of the skin will be assessed by measurement of intradermal wheals with diameters \u2265 5mm and the volume of liquid injected.", 
            "measure": "Proportion of Injections Delivered to the Intradermal Layer of the Skin", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943110"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The proportion of participants with safety events will be calculated for events occurring within 30 minutes and within 48 hours of injection.", 
            "measure": "Proportion of Participants With Safety Events", 
            "safety_issue": "Yes", 
            "time_frame": "2 days"
        }, 
        "source": "PATH", 
        "sponsors": {
            "collaborator": {
                "agency": "SID Technologies", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "PATH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}